Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 331 to 340 of 1520 total matches.

Flecainide for Supraventricular Tachyarrhythmias

   
The Medical Letter on Drugs and Therapeutics • Jul 24, 1992  (Issue 875)
with congestive heart failure or an ejection fraction ...
Flecainide (Tambocor -3M Pharmaceuticals), first introduced in 1985 for treatment of ventricular arrhythmias, was recently approved by the US Food and Drug Administration for oral use to prevent supraventricular arrhythmias. The indications for using flecainide to treat ventricular arrhythmias were limited after a controlled trial found that post-myocardial infarction patients with asymptomatic ventricular arrhythmias who took the drug had twice as high a mortality rate as patients who took placebo (DS Echt et al, N Engl Med, 324:781, 1991).
Med Lett Drugs Ther. 1992 Jul 24;34(875):71-2 |  Show IntroductionHide Introduction

Oral Mesalamine for Ulcerative Colitis

   
The Medical Letter on Drugs and Therapeutics • Aug 21, 1992  (Issue 877)
Letter, Vol. 34 (Issue 877) August 21, 1992, pp. 80-81 Copyright  The Medical Letter UNAUTHORIZED ...
An oral formulation of mesalamine (5-aminosalicylic acid, 5-ASA, Asacol - Proctor & Gamble), was recently approved by the US Food and Drug Administration (FDA) for treatment of mildly to moderately active ulcerative colitis; it has not been approved for maintenance of remissions. Olsalazine (Dipentum), a similar drug (Medical Letter, 32:105, 1990), is approved for maintenance of remissions but not for treatment.
Med Lett Drugs Ther. 1992 Aug 21;34(877):80-1 |  Show IntroductionHide Introduction

Pentostatin and 2-Chlorodeoxyadenosine for Hairy-Cell Leukemia

   
The Medical Letter on Drugs and Therapeutics • Sep 18, 1992  (Issue 879)
or concurrent use with other drugs for these conditions remains to be established. The Medical Letter, Vol. 34 ...
Pentostatin (2'-deoxycoformycin; DCF; - Parke-Davis), a purine analog, was recently approved by the US Food and Drug Administration (FDA) for treatment of hairy-cell leukemia resistant to interferon alfa (Intron A; Roferon-A). is a rare (500 cases/year in the USA) form of chronic lymphocytic leukemia. Acutely ill patients may respond rapidly to interferon, but the drug is rarely curative. Another purine analog, 2-chlorodeoxyadenosine (CdA; Leustatin - Ortho Biotech), may also be approved soon for treatment of hairy-cell leukemia (JD Piro, Blood, 79:843, 1992). Fludarabine (Fludara...
Med Lett Drugs Ther. 1992 Sep 18;34(879):89-90 |  Show IntroductionHide Introduction

Meters for Glucose Monitoring

   
The Medical Letter on Drugs and Therapeutics • Dec 25, 1992  (Issue 886)
in the amount of blood applied, but probably not in every case. The Medical Letter, Vol. 34 (Issue 886 ...
Most patients with diabetes mellitus now test their own blood glucose. In recent years, meters commercially available for self-testing have become smaller and easier to use.
Med Lett Drugs Ther. 1992 Dec 25;34(886):115-6 |  Show IntroductionHide Introduction

Choice of an Antidepressant

   
The Medical Letter on Drugs and Therapeutics • Mar 19, 1993  (Issue 892)
Montgomery, Drugs, 43 suppl 2:24, 1992). The Medical Letter, Vol. 35 (Issue 892) March 19, 1993, pp. 25-26 ...
Since the introduction of fluoxetine (Prozac - Medical Letter, 30:45, 1988), bupropion (Wellbutrin - Medical Letter, 31:97, 1989), sertraline (Zoloft - Medical Letter, 34:47, 1992) and paroxetine (Paxil - this issue), the choice of an antidepressant has become more difficult. Should these widely prescribed new drugs replace tricyclic antidepressants such as amitriptyline (Elavil, and others), imipramine (Tofranil, and others), or nortriptyline (Aventyl, and others) for treatment of most patients with depression?
Med Lett Drugs Ther. 1993 Mar 19;35(892):25-6 |  Show IntroductionHide Introduction

Rifabutin

   
The Medical Letter on Drugs and Therapeutics • Apr 30, 1993  (Issue 895)
, Vol. 35 (Issue 895) April 30, 1993, pp. 36-38 Copyright  The Medical Letter UNAUTHORIZED FORWARDING ...
Rifabutin (formerly ansamycin; Mycobutin - Adria), a rifamycin antibiotic similar to rifampin (Rifadin, Rimactane) was recently approved by the US Food and Drug Administration for prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection.
Med Lett Drugs Ther. 1993 Apr 30;35(895):36-8 |  Show IntroductionHide Introduction

Insect Venom Immunotherapy

   
The Medical Letter on Drugs and Therapeutics • Jul 09, 1993  (Issue 900)
, urticaria or angioedema) without respiratory or cardiovascular symptoms. The Medical Letter, Vol. 35 (Issue ...
Systemic allergic reactions to insect stings can include generalized urticaria, bronchospasm, laryngeal edema, hypotension and death. About 1% to 3% of adults in the USA have had a systemic allergic reaction to an insect sting (RE Reisman, Med Clin North Am, 76:883, 1992; UR M ller, Monogr Allergy, 31:131, 1993).
Med Lett Drugs Ther. 1993 Jul 9;35(900):63-4 |  Show IntroductionHide Introduction

Surgical Treatment of Parkinson's Disease

   
The Medical Letter on Drugs and Therapeutics • Nov 12, 1993  (Issue 909)
imaging (MRI) have made it possible to ablate small areas of the brain with The Medical Letter, Vol. 35 ...
Interest in surgical treatment of Parkinson's disease has increased as the limitations of medical treatment have become apparent (Medical Letter, 35:31, 1993). Two approaches have been used. The first is transplantation of dopamine-producing cells into the patient's brain. The second is stereotactic surgery in areas of the brain that modify movement.
Med Lett Drugs Ther. 1993 Nov 12;35(909):103-4 |  Show IntroductionHide Introduction

Ziac for Hypertension

   
The Medical Letter on Drugs and Therapeutics • Mar 18, 1994  (Issue 918)
treated with The Medical Letter, Vol. 36 (Issue 918) March 18, 1994, pp. 23-24 Copyright  The Medical ...
Ziac (Lederle), a combination of the beta-blocker bisoprolol fumarate and a very low dose (6.25 mg) of the diuretic hydrochlorothiazide, has been approved for treatment of hypertension by the US Food and Drug Administration (FDA). Bisoprolol, a new cardioselective beta-blocker with no intrinsic sympathomimetic activity, has also been marketed as a single drug (Zebeta - Lederle). The manufacturer is promoting the combination for initial treatment of hypertension with the claim that the low doses of the two drugs used together are effective in lowering blood pressure, but are each too low ...
Med Lett Drugs Ther. 1994 Mar 18;36(918):23-4 |  Show IntroductionHide Introduction

Oral Transmucosal Fentanyl Citrate

   
The Medical Letter on Drugs and Therapeutics • Mar 18, 1994  (Issue 918)
with the opioid antagonist naloxone (Narcan, and others). The Medical Letter, Vol. 36 (Issue 918) March 18, 1994 ...
Fentanyl, a synthetic opioid previously available for parenteral use in anesthesia (Sublimaze, and others) and in a transdermal patch for chronic pain (Duragesic - Medical Letter, 34:97, 1992), has now also been marketed as a raspberry-colored lozenge on a plastic handle (Fentanyl Oralet - Abbott), which resembles a lollipop. The new formulation will probably be promoted mainly for premedication of children before anesthesia, but has also been approved by the US Food and Drug Administration (FDA) for preanesthetic use in adults and for use in anesthesia or 'monitored anesthesia care' in...
Med Lett Drugs Ther. 1994 Mar 18;36(918):24-5 |  Show IntroductionHide Introduction